The risks centre on two clusters: premature deployment without regulatory oversight, and misapplication where AI isn't actually solving the problem.
On regulation, the immediate concern is uncontrolled proliferation of generative AI tools bypassing clinical governance. Lifestyle apps powered by generative AI can sidestep healthcare regulation while offering medical advice—telling users what painkiller to take or diagnosing headache types without any human approval [#412]. That uncontrolled rollout matters because healthcare systems are already under acute pressure from staffing shortages and an ageing population [#429], making them vulnerable to the false promise of quick AI fixes.
The second risk is waste and workflow chaos. Unrealistic expectations about what generative AI can do lead to misallocated resources, too many pilots, and a pile-up of narrow, disconnected tools that actually worsen clinician burden rather than ease it [#412]. The risk is flooding already exhausted staff with a hundred spell-checkers instead of genuinely integrating tools that fit actual clinical workflows [#356]. Both problems point to the same solution: deploying generative AI where there's proven, high-impact ROI and human oversight in the loop, not because the technology is new.
Search 450+ episodes and 42,000 chunks of healthtech conversation.